Analyst price target range

GRI Bio Price Target: $18.50 Average

Direct answer

GRI Bio's average price target is $18.50.

The verified analyst range runs from $10.00 to $27.00.
The low target implies +614.3%, the high target implies +1,828.6%, and the range spans 1,214.3% of the current price.
Forecast evidence checked November 17, 2026.

Get free GRI Bio email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.40
Average price target
$18.50
High price target
$27.00
Low price target
$10.00
Low target gap
+614.3%
Target upside
+1,221.4%
High target gap
+1,828.6%
Target range width
1,214.3%
Consensus rating
none
Analysts
2
Evidence date
November 17, 2026
Valid through
November 24, 2026

Read the frequently asked questions.

What is GRI Bio's average price target?

GRI Bio's verified average price target is $18.50. The target range is $10.00 to $27.00.

How far are GRI Bio's low and high targets from the recorded price?

The low target implies +614.3%, while the high target implies +1,828.6%.

How many analysts are included in GRI Bio's consensus?

The verified consensus includes 2 analysts.

How is GRI Bio's target upside or downside calculated?

The average target of $18.50 is divided by the recorded price of $1.40, then one is subtracted to produce +1,221.4%. This does not guarantee a future return.

When was GRI Bio's analyst forecast verified?

The data was verified on 2026-11-17. The dataset is valid through 2026-11-24.